• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性肝癌二级预防共识。

Consensus on the secondary prevention of primary liver cancer.

机构信息

Department of Traditional and Western Medical Hepatology, The Third Hospital of Hebei Medical University, Shijiazhuang, 050051, China.

Department of Infectious Diseases, Peking University First Hospital, Beijing, 100034, China.

出版信息

Hepatol Int. 2021 Dec;15(6):1289-1300. doi: 10.1007/s12072-021-10259-7. Epub 2021 Nov 30.

DOI:10.1007/s12072-021-10259-7
PMID:34846705
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8712303/
Abstract

To standardize the effective prevention, surveillance, and diagnosis of primary liver cancer, the Chinese Society of Hepatology, Chinese Medical Association, invited clinical experts and methodologists to develop the Consensus on the Secondary Prevention of Primary Liver Cancer, which was based on the clinical and scientific advances on hepatocellular carcinoma. The purpose is to provide a current basis for the prevention, surveillance, and early diagnosis of primary liver cancer in patients with chronic liver diseases.

摘要

为规范原发性肝癌的有效防治和诊断,中华医学会肝病学分会、感染病学分会组织临床专家和方法学专家,基于近年来国内外肝癌诊疗进展,制定了《原发性肝癌二级预防共识》,旨在为慢性肝病患者原发性肝癌的防治和早期诊断提供当前依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9326/8712303/3eb189f0a41a/12072_2021_10259_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9326/8712303/455d10141b80/12072_2021_10259_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9326/8712303/c8311f85e370/12072_2021_10259_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9326/8712303/3eb189f0a41a/12072_2021_10259_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9326/8712303/455d10141b80/12072_2021_10259_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9326/8712303/c8311f85e370/12072_2021_10259_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9326/8712303/3eb189f0a41a/12072_2021_10259_Fig3_HTML.jpg

相似文献

1
Consensus on the secondary prevention of primary liver cancer.原发性肝癌二级预防共识。
Hepatol Int. 2021 Dec;15(6):1289-1300. doi: 10.1007/s12072-021-10259-7. Epub 2021 Nov 30.
2
[Consensus on secondary prevention of primary liver cancer (2021 version)].原发性肝癌二级预防共识(2021年版)
Zhonghua Gan Zang Bing Za Zhi. 2021 Mar 20;29(3):216-226. doi: 10.3760/cma.j.cn501113-20210210-00082.
3
Consensus on the tertiary prevention of primary liver cancer.原发性肝癌三级预防共识。
Hepatol Int. 2023 Oct;17(5):1057-1071. doi: 10.1007/s12072-023-10549-2. Epub 2023 Jun 27.
4
Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan.肝癌管理共识指南:2016 年由台湾肝癌医学会和台湾消化系医学会更新。
J Formos Med Assoc. 2018 May;117(5):381-403. doi: 10.1016/j.jfma.2017.09.007. Epub 2017 Oct 24.
5
Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version.日本肝细胞癌的管理:日本肝脏学会(JSH)2010 年更新版提出的基于共识的临床实践指南。
Dig Dis. 2011;29(3):339-64. doi: 10.1159/000327577. Epub 2011 Aug 9.
6
[The consensus on tertiary prevention of primary liver cancer (2022 version)].《原发性肝癌三级预防共识(2022年版)》
Zhonghua Gan Zang Bing Za Zhi. 2022 Aug 20;30(8):832-845. doi: 10.3760/cma.j.cn501113-20220616-00330.
7
Prevention of hepatocellular carcinoma in the Asia-Pacific region: consensus statements.亚太地区肝细胞癌的预防:共识声明。
J Gastroenterol Hepatol. 2010 Apr;25(4):657-63. doi: 10.1111/j.1440-1746.2009.06167.x.
8
Chinese guidelines on the management of liver cirrhosis (abbreviated version).《肝硬化诊治指南(简版)》(中国版)
World J Gastroenterol. 2020 Dec 7;26(45):7088-7103. doi: 10.3748/wjg.v26.i45.7088.
9
[Primary and secondary prevention of HBV-related hepatocellular carcinoma by antiviral treatment].通过抗病毒治疗进行乙肝相关肝细胞癌的一级和二级预防
Nihon Rinsho. 2015 Dec;73 Suppl 9:559-64.
10
The African Middle Eastern Society for Digestive Oncology mission against viral hepatitis and hepatocellular carcinoma.非洲中东消化肿瘤学会对抗病毒性肝炎和肝细胞癌的使命。
Arab J Gastroenterol. 2013 Mar;14(1):31-3. doi: 10.1016/j.ajg.2012.12.003. Epub 2013 Jan 20.

引用本文的文献

1
Physical activity and exercise in liver cancer.肝癌中的体力活动与运动
Liver Res. 2024 Mar 8;8(1):22-33. doi: 10.1016/j.livres.2024.03.001. eCollection 2024 Mar.
2
Exploiting gender-based biomarkers and drug targets: advancing personalized therapeutic strategies in hepatocellular carcinoma.利用基于性别的生物标志物和药物靶点:推进肝细胞癌的个性化治疗策略
Front Pharmacol. 2024 Jun 20;15:1433540. doi: 10.3389/fphar.2024.1433540. eCollection 2024.
3
Application of the Multi-Omics Liquid Biopsy Method M2P-HCC in Early Liver Cancer Screening for High-Risk Individuals with Hepatitis B-Related Liver Cancer.

本文引用的文献

1
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
2
Incidence of HCC in chronic hepatitis C patients with advanced hepatic fibrosis who achieved SVR following DAAs: A prospective study.直接抗病毒药物治疗后获得病毒学应答的晚期纤维化慢性丙型肝炎患者中 HCC 的发生率:一项前瞻性研究。
J Viral Hepat. 2020 Jul;27(7):671-679. doi: 10.1111/jvh.13276. Epub 2020 Mar 4.
3
AFP specificity for HCC surveillance is increased by mitigating liver injury among treated chronic hepatitis B patients with elevated AFP.
多组学液体活检方法M2P-HCC在乙肝相关肝癌高危个体早期肝癌筛查中的应用
Diagnostics (Basel). 2023 Jul 26;13(15):2484. doi: 10.3390/diagnostics13152484.
4
Prevention of malignant digestive system tumors should focus on the control of chronic inflammation.消化系统恶性肿瘤的预防应着重于慢性炎症的控制。
World J Gastrointest Oncol. 2023 Mar 15;15(3):389-404. doi: 10.4251/wjgo.v15.i3.389.
5
The clinical management of hepatocellular carcinoma in China: Progress and challenges.中国肝细胞癌的临床管理:进展与挑战。
Clin Mol Hepatol. 2023 Apr;29(2):339-341. doi: 10.3350/cmh.2023.0077. Epub 2023 Mar 16.
6
Evaluation of Therapeutic Effects of Computed Tomography Imaging Classification Algorithm-Based Transcatheter Arterial Chemoembolization on Primary Hepatocellular Carcinoma.基于计算机断层成像分类算法的经导管动脉化疗栓塞治疗原发性肝癌的疗效评价。
Comput Intell Neurosci. 2022 Apr 22;2022:5639820. doi: 10.1155/2022/5639820. eCollection 2022.
通过减轻治疗后甲胎蛋白(AFP)升高的慢性乙型肝炎患者的肝损伤,可提高AFP对肝癌监测的特异性。
Int J Clin Exp Pathol. 2019 Apr 1;12(4):1315-1323. eCollection 2019.
4
B-Mode Ultrasonography versus Contrast-Enhanced Ultrasonography for Surveillance of Hepatocellular Carcinoma: A Prospective Multicenter Randomized Controlled Trial.B超与超声造影在肝细胞癌监测中的对比:一项前瞻性多中心随机对照试验
Liver Cancer. 2019 Jul;8(4):271-280. doi: 10.1159/000501082. Epub 2019 Jun 6.
5
Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohorts.在四个欧洲队列中对诊断为非酒精性脂肪性肝病的成年人进行的真实世界研究:肝硬化和肝细胞癌诊断的风险和临床预测因子。
BMC Med. 2019 May 20;17(1):95. doi: 10.1186/s12916-019-1321-x.
6
Global liver disease burdens and research trends: Analysis from a Chinese perspective.全球肝脏疾病负担与研究趋势:中国视角分析。
J Hepatol. 2019 Jul;71(1):212-221. doi: 10.1016/j.jhep.2019.03.004. Epub 2019 Mar 12.
7
Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study.直接作用抗病毒治疗后慢性丙型肝炎患者的临床结局:一项前瞻性队列研究。
Lancet. 2019 Apr 6;393(10179):1453-1464. doi: 10.1016/S0140-6736(18)32111-1. Epub 2019 Feb 11.
8
Longitudinal Assessment of Three Serum Biomarkers to Detect Very Early-Stage Hepatocellular Carcinoma.三种血清生物标志物用于早期检测肝细胞癌的纵向评估。
Hepatology. 2019 May;69(5):1983-1994. doi: 10.1002/hep.30233. Epub 2019 Feb 20.
9
Noninvasive imaging of hepatocellular carcinoma: From diagnosis to prognosis.肝细胞癌的无创性影像学诊断与预后评估。
World J Gastroenterol. 2018 Jun 14;24(22):2348-2362. doi: 10.3748/wjg.v24.i22.2348.
10
Management of Hepatocellular Carcinoma in Japan as a World-Leading Model.日本肝细胞癌的管理作为全球领先模式
Liver Cancer. 2018 May;7(2):134-147. doi: 10.1159/000484619. Epub 2017 Dec 13.